Production of Sputnik V in S. Korea to kick off in May
A subsidiary of South Korean bio-tech company GL Rapah will begin producing Russian COVID-19 vaccines in the country in May, with all doses bound for export, industry sources said Tuesday. Under the agreement with Russia's sovereign wealth fund, Russian Direct Investment Fund (RDIF), Hankook Korus will first manufacture 150 million doses of Sputnik V at a local factory, they said. All of the doses manufactured in South Korea will be for export and not for domestic usage.
Source: en.yna.co.kr